Health Canada expands Ozempic approval to include reducing the risk of heart attacks and strokes in adults with type 2 diabetes and heart or kidney disease.
Appetite-suppressing GLP-1 medications may be changing the way Canadians eat – Smaller appetites and healthier choices are impacting restaurants and the food supply sector in significant ways.
A major international study called The FLOW trial has resulted in approval for Ozempic from Health Canada to help treat CKD in people with type 2 diabetes.
Weight loss drugs like Ozempic are changing lives but as with all medications, they can come with side effects. Learn more about the risks scientists are discovering as their use becomes more widespread.
Health Canada warns against unapproved peptide injections trending online for weight loss and anti-aging, citing serious health risks and lack of regulation.